Publication
Number of items: 25.
10 June 2024
  • Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II. (2024) Lisa A. Lione and Amy Fisher
    • 7 November 2023
  • Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy. (2023) Cijo George Vazhappilly, Shoib Sarwar Siddiqui, Ruby John Anto, Rajan Radhakrishnan and Naveen Kumar Devanga Ragupathi
    • 13 June 2023
  • Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review. (2023) Stefanie Ho Yi Chan, Yasmin Khatib, Sherael Webley, Deborah Layton and Sam Salek
    • 9 May 2023
  • Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry. (2023) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek
    • 25 November 2022
  • Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries. (2022) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek
    • 3 November 2022
  • Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek
    • 15 September 2022
  • Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain. (2022) Lisa A. Lione and Amy Fisher
    • 5 July 2022
  • Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek
    • 9 August 2021
  • Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021) Hasumati Rahalkar, Alan Sheppard and Sam Salek
    • 23 July 2021
  • South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access. (2021) Andrea Keyter, Sam Salek, Lorraine Danks, Portia Nkambule, Boitumelo Semete-Makokotlela and Stuart Walker
    • 8 February 2021
  • Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research : Translatable and Bidirectional Research. (2021) Amy Fisher, Michael Lanigan, Neil Upton and Lisa Lione
    • 5 March 2020
  • Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO) : Content Validity. (2020) Pushpendra Goswami, Esther Oliva, Tatyana Ionova, R Else, J Kell, AK Fielding, DM Jennings, M Karakantza, S Al-Ismail, GP Collins, S McConnell, Catherine Langton and Sam Salek
    • 29 March 2019
  • Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal
    • 14 March 2019
  • The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland. (2019) Andrea Keyter, Mir-Saeed Shayegan Salek, Shabir Banoo and Stuart R. Walker
    • 18 February 2019
  • Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal
    • 1 February 2019
  • Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems. (2019) Fabrizio Schifano, Stephania Chiappini, John Corkery and Amira Guirguis
    • 4 December 2018
  • The South African Regulatory System: Past, Present, and Future. (2018) A Keyter, Shabir Banoo, Mir-Saeed Shayegan Salek and Stuart R. Walker
    • 27 November 2018
  • Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service. (2018) Dalia M Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier Griffin, Beverley J Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Chahal, Carlos Sharpin and Peter Barry
    • 28 September 2018
  • Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines. (2018) Hasumati Rahalkar, Hacer Coskun Cetintas and Mir-Saeed Shayegan Salek
    • 13 August 2018
  • Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. (2018) Uchini S Kosgodage, Rhys Mould, Aine Henley, alistair Nunn, Geoffrey Guy, E. Louise Thomas, Jameel Inal, Jimmy Bell and Sigrun Lange
    • 21 March 2018
  • Is there a potential of misuse for venlafaxine and bupropion? (2018) Fabrizio Schifano and Stephania Chiappini
    • 30 June 2017
  • A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? (2017) Nicola Allen, Lawrence Liberti, Stuart R. Walker and Sam Salek
    • 10 April 2017
  • Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment : A Systematic Review of the Literature. (2017) M Bujar, N McAuslane, S Walker and Mir-Saeed Shayegan Salek
    • 13 July 2016
  • The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making. (2016) R Donelan, Stuart Walker and Mir-Saeed Shayegan Salek
    • 11 June 2015
  • A practical approach to communicating benefit-risk decisions of medicines to stakeholders. (2015) J Leong, S Walker and Mir-Saeed Shayegan Salek